In how many countries KEYTRUDA is approved for marketing?
KEYTRUDA is available/approved in USA and Europe. We can help you to access it in India.
What is KEYTRUDA used for?
KEYTRUDA is a programmed death receptor-1 (PD-1)-blocking antibody indicated:
- Non-Small Cell Lung Cancer
- Head and Neck Squamous Cell Cancer
- Classical Hodgkin Lymphoma
- Primary Mediastinal Large B-Cell Lymphoma
- Urothelial Carcinoma
- Microsatellite Instability-High Cancer
- Gastric Cancer
- Cervical Cancer
How can I get KEYTRUDA in India?
KEYTRUDA is a prescription only drug and is not approved for marketing in India. The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations. Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at –firstname.lastname@example.org
We facilitate by:-
- Helping in documentation to import the medicine for personal use
- Finding Genuine and reliable source in USA, Europe and Japan
- Ensuring 100% transparency.
KEYTRUDA can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.
The Indian Pharma can facilitate the supply of KEYTRUDA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.
The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees